Shanghai Allist Pharmaceuticals Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100005XJ7
CNY
95.00
-1.5 (-1.55%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
1,583.78
1,454.32
1,359.26
1,275.39
1,098.37
1,024.45
957.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,583.78
1,454.32
1,359.26
1,275.39
1,098.37
1,024.45
957.00
Raw Material Cost
80.59
54.03
54.59
47.29
44.48
46.01
46.36
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.03
0.01
0.05
0.04
0.04
0.02
0.02
Selling and Distribution Expenses
645.49
648.27
560.20
513.64
504.72
476.38
402.69
Other Expenses
11.37
9.57
10.74
10.43
8.72
10.23
7.19
Total Expenditure (Excl Depreciation)
839.80
798.00
722.19
665.27
636.46
624.66
520.92
Operating Profit (PBDIT) excl Other Income
744
656.3
637.1
610.1
461.9
399.79999999999995
436.1
Other Income
13.45
11.07
25.72
155.63
17.93
28.40
47.68
Operating Profit (PBDIT)
734.54
659.65
656.03
758.70
474.90
426.20
479.47
Interest
0.03
0.01
0.05
0.04
0.04
0.02
0.02
Exceptional Items
6.96
8.31
8.97
11.58
11.44
11.18
9.42
Gross Profit (PBDT)
1,503.19
1,400.30
1,304.66
1,228.10
1,053.89
978.44
910.64
Depreciation
0.00
11.71
11.71
10.54
10.54
9.92
9.92
Profit Before Tax
741.46
656.24
653.24
759.70
475.76
427.45
478.95
Tax
105.41
82.91
88.70
118.96
65.27
60.55
72.14
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
636.04
573.33
564.54
640.74
410.50
366.90
406.81
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
636.04
573.33
564.54
640.74
410.50
366.90
406.81
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
636.04
573.33
564.54
640.74
410.50
366.90
406.81
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
7,743.80
7,083.20
6,498.81
6,130.94
5,637.20
5,282.81
4,863.02
Earnings per share (EPS)
1.41
1.27
1.25
1.42
0.91
0.82
0.9
Diluted Earnings per share
1.41
1.27
1.25
1.42
0.91
0.82
0.9
Operating Profit Margin (Excl OI)
45.53%
43.79%
45.51%
46.46%
40.64%
37.86%
44.08%
Gross Profit Margin
46.82%
45.93%
48.92%
60.39%
44.27%
42.69%
51.08%
PAT Margin
40.16%
39.42%
41.53%
50.24%
37.37%
35.81%
42.51%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Mar 2026 is 8.90% vs 6.99% in Dec 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Mar 2026 is 10.94% vs 1.56% in Dec 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Mar 2026 is 11.18% vs 2.90% in Dec 2025

stock-summary

Interest

No Interest in the last few periods

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

Compare Quarterly Results Of Shanghai Allist Pharmaceuticals Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
1,583.78
0
1,583.78
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,583.78
0
1,583.78
Raw Material Cost
80.59
0
80.59
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.03
0
0.03
Selling and Distribution Expenses
645.49
0
645.49
Other Expenses
11.37
0.00
11.37
Total Expenditure (Excl Depreciation)
839.80
0
839.80
Operating Profit (PBDIT) excl Other Income
743.98
0.00
743.98
Other Income
13.45
0
13.45
Operating Profit (PBDIT)
734.54
0
734.54
Interest
0.03
0
0.03
Exceptional Items
6.96
0
6.96
Gross Profit (PBDT)
1,503.19
0
1,503.19
Depreciation
0.00
0
0.00
Profit Before Tax
741.46
0
741.46
Tax
105.41
0
105.41
Provisions and contingencies
0
0
0.00
Profit After Tax
636.04
0
636.04
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
636.04
0
636.04
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
636.04
0
636.04
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
7,743.80
0
7,743.80
Earnings per share (EPS)
1.41
0
1.41
Diluted Earnings per share
1.41
0
1.41
Operating Profit Margin (Excl OI)
45.53%
0%
0.00
45.53%
Gross Profit Margin
46.82%
0%
0.00
46.82%
PAT Margin
40.16%
0%
0.00
40.16%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 158.38 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 8.90% vs 6.99% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 44.19% vs 47.87% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 63.60 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 10.94% vs 1.56% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 54.93% vs 34.11% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 72.11 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 11.18% vs 2.90% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 57.79% vs 54.50% in Mar 2025

Quarterly - Interest
Markets Mojo
No Interest in the last few periods
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 45.53%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025